Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes - observations from the TARGET trial

I Casserly; Eric Topol; G Jia; C Hamm; null Meier; P Di Battiste; N Lakkis; Derek Chew; G Stone; David Cohen; David Moliterno

Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes - observations from the TARGET trial

I Casserly, Eric Topol, G Jia, C Hamm, Meier, P Di Battiste, N Lakkis, Derek Chew, G Stone, David Cohen, David Moliterno

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Original language	English
Article number	CC
Pages (from-to)	125-129
Number of pages	5
Journal	American Journal of Cardiology
Volume	92
Issue number	2
Publication status	Published - 2003

Cite this

@article{db19fd53fa0a4ac5b7a79db3dcf6fb2b,

title = "Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes - observations from the TARGET trial",

author = "I Casserly and Eric Topol and G Jia and C Hamm and Meier and {Di Battiste}, P and N Lakkis and Derek Chew and G Stone and David Cohen and David Moliterno",

year = "2003",

language = "English",

volume = "92",

pages = "125--129",

journal = "American Journal of Cardiology",

issn = "0002-9149",

publisher = "EXCERPTA MEDICA",

number = "2",

}

TY - JOUR

T1 - Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes - observations from the TARGET trial

AU - Casserly, I

AU - Topol, Eric

AU - Jia, G

AU - Hamm, C

AU - Meier, null

AU - Di Battiste, P

AU - Lakkis, N

AU - Chew, Derek

AU - Stone, G

AU - Cohen, David

AU - Moliterno, David

PY - 2003

Y1 - 2003

M3 - Article

VL - 92

SP - 125

EP - 129

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 2

M1 - CC

ER -